Overview

Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether a difference between two doses of formoterol can be detected by methacholine challenge.
Phase:
N/A
Details
Lead Sponsor:
University of Florida
Collaborators:
Teva Branded Pharmaceutical Products R&D, Inc.
Teva Branded Pharmaceutical Products, R&D Inc.
Treatments:
Formoterol Fumarate
Methacholine Chloride